Alterity Therapeutics - ADR Financials

$4.11

$-0.39 (-8.67%)

As on 10-Sep-2026 16:00EDT

Market cap

$83 Mln

Revenue (TTM)

$6 Mln

P/E Ratio

--

P/B Ratio

2.7

Div. Yield

0 %

Annual
Quarterly

Income Statement (A$ Mln)	Jun-26	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16
Operating Revenue	--	5.44	4.02	3.92	5.12	4.34
Cost of Revenue	0.11	0.13	0.21	0.29	0.36	0.36
Gross Profit	-0.11	5.31	3.80	3.63	4.76	3.98
Operating Expenses	27.69	19.89	23.41	18.24	20.26	19.16
Operating Profit (EBIT)	-27.80	-14.57	-19.60	-14.64	-15.50	-15.18
Other Income	--	--	--	--	--	--
Profit before Tax	-26.31	-12.08	-19.08	-13.70	-12.78	-15.31
Provision for Tax	-3.42	0.07	0.05	0.10	0.07	-3.08
Profit after Tax (Net Income)	-22.89	-12.15	-19.12	-13.81	-12.85	-15.31
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	-13.81	-12.85	-15.31

Liabilities (A$ Mln)	Jun-26	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16
Shareholder's Funds	42.73	42.40	13.80	22.81	35.47	30.47
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.14	0.09	0.05	0.12	0.07	0.05
Current Liabilities	3.16	3.53	5.37	4.38	5.82	3.07
Total Liabilities	46.02	46.03	19.22	27.32	41.36	33.59

Assets (A$ Mln)	Jun-26	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16
Non-Current Assets	0.19	0.16	0.19	0.27	0.22	0.10
Current Assets	45.83	45.87	19.04	27.05	41.14	33.49
Total Assets	46.02	46.03	19.22	27.32	41.36	33.59
Total Debt*	0.19	0.16	0.16	0.21	0.12	0.07
Net Current Assets	42.67	42.34	13.66	22.67	35.32	30.42

Cashflow (A$ Mln)	Jun-26	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16
Cash From Operating Activities	-22.03	-11.45	-12.61	-20.04	-12.34	-17.33
Cash Flow from Investing Activities	7.34	-7.50	-0.01	-0.04	-0.09	-0.01
Cash from Financing Activities	18.71	39.67	9.22	0.12	16.30	36.69
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	Jun-26	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16
Adjusted EPS (A$)	-1.26	-0.97	-1.82	-3.40	-3.20	-4.41
Cash EPS (A$)	-1.26	-0.96	-1.80	-3.37	-3.19	-4.39
Adjusted Book Value (A$)	2.36	3.40	1.31	5.61	8.84	8.77
Dividend per Share (A$)	--	--	--	--	--	--
Cash Flow per Share (A$)	-1.22	-0.92	-1.20	-4.93	-3.08	-4.99
Free Cash Flow per Share (A$)	-1.24	-0.92	-1.20	-4.93	-3.10	-4.99

Profitability Ratios	Jun-26	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16
ROCE (%)	-53.56	-42.99	-103.42	-47.11	-38.86	-74.47
ROE (%)	-53.78	-43.23	-104.47	-47.38	-38.97	-74.65
ROA (%)	-49.73	-37.23	-82.18	-40.21	-34.28	-65.30
EBIT Margin (%)	--	-269.57	-487.82	-373.72	-340.52	-349.77
Net Margin (%)	--	-223.35	-475.79	-352.54	-250.75	-352.78
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Jun-26	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16
Revenue Growth (%)	-1.00	0.35	0.03	-0.24	0.18	9.54
EBIT Growth (%)	-89.61	25.22	-33.96	16.11	-14.94	-12.79
Net Profit Growth (%)	-88.43	36.48	-38.51	-7.47	16.08	-52.19
EPS Growth (%)	-0.30	0.46	0.46	-0.06	0.27	0.33
Book Value Growth (%)	--	--	--	--	--	--

Solvency Ratios	Jun-26	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16
Debt to Equity	0.00	0.00	0.01	0.01	0.00	0.00
Short term debt to equity ratio	0.00	0.00	0.01	0.00	0.00	0.00
Current Ratio	14.52	12.98	3.54	6.17	7.07	10.92
Quick Ratio	--	--	3.55	5.59	6.79	10.92
Interest Coverage	--	--	--	--	-6,967.44	--

Operating Efficiency Ratios	Jun-26	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16
Debtors to sales (%)	--	72.40	100.56	220.84	91.14	95.09
Asset Turnover	--	0.17	0.17	0.11	0.14	0.19
Receivable days	--	267.92	576.62	621.05	313.52	176.23
Inventory Days	--	-64.13	2,170.61	2,672.25	802.13	288.06
Payable days	2,678.46	1,603.11	1,957.68	2,787.67	2,045.17	1,218.72
Cash Conversion Cycle	--	-1,399.31	789.55	505.63	-929.52	-754.43